AF
DNLI icon

Allworth Financial’s Denali Therapeutics DNLI Stock Holding History

Allworth Financial’s Portfolio DNLI Stock Details DNLI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$47.2K Buy
1,834
+1,554
+555% +$31.9K ﹤0.01% 2545
2026
Q1 		$5.38K Buy
280
+190
+211% +$3.78K ﹤0.01% 3919
2025
Q4 		$1.49K Sell
90
-9
-9% -$152 ﹤0.01% 4230
2025
Q3 		$1.44K Sell
99
-176
-64% -$2.53K ﹤0.01% 4142
2025
Q2 		$3.85K Sell
275
-28
-9% -$394 ﹤0.01% 3407
2025
Q1 		$4.69K Buy
303
+293
+2,930% +$5.61K ﹤0.01% 2791
2024
Q4 		$234 Buy
+10
New +$256 ﹤0.01% 3755
2024
Q3 		– Sell
-64
Closed -$1.37K – 3768
2024
Q2 		$1.37K Sell
64
-22
-26% -$422 ﹤0.01% 3058
2024
Q1 		$1.76K Sell
86
-803
-90% -$15.1K ﹤0.01% 2852
2023
Q4 		$19.1K Buy
889
+840
+1,714% +$16.6K ﹤0.01% 1679
2023
Q3 		$1.01K Buy
+49
New +$1.24K ﹤0.01% 2846
2023
Q2 		– Sell
-8
Closed -$185 – 3287
2023
Q1 		$185 Hold
8
– – ﹤0.01% 3023
2022
Q4 		$222 Hold
8
– – ﹤0.01% 2769
2022
Q3 		$0 Hold
8
– – ﹤0.01% 2755
2022
Q2 		$0 Buy
+8
New +$210 ﹤0.01% 2486

Other funds holding DNLI

T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $37.3B AUM 12.6% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Allworth Financial's DNLI Position: Q2 2026 in Review

Allworth Financial increased its Denali Therapeutics (DNLI) stake by 555% in Q2 2026, buying an estimated $31.9K and bringing the position to 1,834 shares worth $47.2K. The position accounts for ﹤0.01% of the portfolio, ranked #2545.

Allworth Financial first reported a position in DNLI in Q2 2022 and has held it in 15 quarters since. 292 funds tracked by Wall St. Rank hold DNLI as of Q2 2026.

  • Allworth Financial held 1,834 shares of Denali Therapeutics worth $47.2K as of Q2 2026.
  • Allworth Financial bought 1,554 Denali Therapeutics shares in Q2 2026, an estimated $31.9K.
  • Denali Therapeutics made up ﹤0.01% of Allworth Financial's portfolio in Q2 2026, its #2545 holding.
  • Allworth Financial first reported a position in Denali Therapeutics in Q2 2022 and has held it in 15 quarters since.
  • 292 funds tracked by Wall St. Rank held Denali Therapeutics as of Q2 2026.

Based on Allworth Financial's 13F filing for Q2 2026, filed 11 Aug 2026.